Equity (Tables)

12 Months Ended

Dec. 31, 2020

Equity

Schedule of status of the restricted stock grants issued under the Equity Plan

	The Year Ended December 31,
	2020			2019
		Weighted			Weighted
		Average Grant			Average
		Date Fair			Grant Date
	Number of	Value Per		Number of	Fair Value
Restricted Stock Grants	Shares	Share		Shares	Per Share
Outstanding at December 31, 2019	318,003	$	0.30	340,001	$	0.45
Granted during the period	300,000		0.42	312,000		0.26
Restrictions lifted during the period	(394,001)		0.36	(333,998)		0.41
Forfeited during the period	—		—	—		—
Outstanding December 31, 2020	224,002	$	0.36	318,003	$	0.30

Schedule of status of the stock option grants issued under the Equity Plan

	The Year Ended December 31,
	2020			2019
		Weighted			Weighted
		Average			Average
		Exercise			Exercise
	Number of	Price Per		Number of	Price Per
Equity Plan Options	Shares	Share		Shares	Share
Outstanding at December 31, 2019	30,310	$	8.06	30,310	$	8.06
Granted during the period	—		—	—		—
Forfeited or expired during period	(30,310)	$	8.06	—		—
Exercised during period	—		—	—		—
Outstanding December 31, 2020	—	$	—	30,310	$	8.06
Exercisable at end of period	—	$	—	30,310	$	8.06
Granted and vested	—	$	—	30,310	$	8.06

Schedule of restricted stock units

	The Year Ended December 31,
	2020			2019
		Weighted			Weighted
		Average Grant			Average
		Date Fair			Grant Date
	Number of	Value Per		Number of	Fair Value
Restricted Stock Units	Shares	Share		Shares	Per Share
Outstanding at December 31, 2019	2,830,038	$	0.78	2,230,038	$	0.93
Granted during the period	780,000		0.40	600,000		0.24
Restrictions lifted during the period	—		—	—		—
Forfeited during the period	—		—	—		—
Outstanding December 31, 2020	3,610,038	$	0.70	2,830,038	$	0.78

Summary of the status of the Company's common stock warrants

	The Year Ended December 31,
	2020			2019
		Weighted			Weighted
	Number of	Average Exercise		Number of	Average Exercise
	Underlying	Price Per		Underlying	Price Per
Common Stock Warrants	Shares	Share		Shares	Share
Outstanding at December 31, 2019	14,653,846	$	0.39	11,517,696	$	0.81
Granted during the period:
Series A warrants	7,500,000		0.30	8,653,846		0.35
Series B warrants	3,750,000		0.30	—
Dilution adjustment	—		—	168,669		0.80
Expired during period	—		—	(5,686,365)		0.80
Exchanged during the period:
May 2016 warrants	—		—	(4,500,000)		0.75
Series B warrants	—		—	4,500,000		0.35
Exercised during period	(8,500,000)		0.30	—		—
Outstanding December 31, 2020	17,403,846	$	0.38	14,653,846	$	0.39